Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Dose Intervals for Oral Cholera Vaccine
NCT03373669Phase 4Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Nov 2017
- Primary completion
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of cholera vaccine (inactivated, oral) in cholera, sponsored by Johns Hopkins Bloomberg School of Public Health. Started Nov 2017; status: completed.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT03373669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373669.